home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights
Tyra Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights
Post navigation
Previous Post
Previous
FLARE THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $123 MILLION SERIES B FINANCING
Next Post
Next
CULLINAN ONCOLOGY ANNOUNCES U.S. FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CLN-617, A NOVEL FUSION PROTEIN HARNESSING IL-2 AND IL-12 CYTOKINES